BoNT‐A vs serial casting
Adverse events · children with CP
BoNT‐A showed no clear difference in adverse events compared with serial casting (low certainty).
3 findings from 1 review
- Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes onlyRR 0.59 [0.03, 11.03]3 studies · 64 participantsLow
- Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
- Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found